Management of thyroid eye disease: a Consensus Statement by the American Thyroid Association and the European Thyroid Association
| Autor: | Henry B. Burch, Petros Perros, Tomasz Bednarczuk, David S. Cooper, Peter J. Dolman, Angela M. Leung, Ilse Mombaerts, Mario Salvi, Marius N. Stan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: |
METHYLPREDNISOLONE PULSE THERAPY
Consensus Endocrinology Diabetes and Metabolism Clinical Sciences consensus statement ORBITAL RADIOTHERAPY Hyperthyroidism SINGLE-BLIND DYSTHYROID OPTIC NEUROPATHY Endocrinology & Metabolism DOUBLE-BLIND Endocrinology European Thyroid Association Clinical Research QUALITY-OF-LIFE MODERATE-TO-SEVERE Humans SEVERE GRAVES ORBITOPATHY Science & Technology thyroid eye disease RANDOMIZED CONTROLLED-TRIAL United States INTRAVENOUS GLUCOCORTICOIDS Europe Graves Ophthalmopathy American Thyroid Association Life Sciences & Biomedicine |
| Zdroj: | Thyroid : official journal of the American Thyroid Association, vol 32, iss 12 European thyroid journal, vol 11, iss 6 |
| Popis: | Thyroid eye disease (TED) remains challenging for clinicians to evaluate and manage. Novel therapies have recently emerged, and their specific roles are still being determined. Most patients with TED develop eye manifestations while being treated for hyperthyroidism and under the care of endocrinologists. Endocrinologists, therefore, have a key role in diagnosis, initial management, and selection of patients who require referral to specialist care. Given that the need for guidance to endocrinologists charged with meeting the needs of patients with TED transcends national borders, and to maximize an international exchange of knowledge and practices, the American Thyroid Association and European Thyroid Association joined forces to produce this consensus statement. ispartof: THYROID vol:32 issue:12 pages:1439-1470 ispartof: location:United States status: published |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|